An Osaka University-led research team has recently published findings that provide a ray of hope for the millions of Parkinson’s disease (PD) sufferers worldwide. Although more common in those aged over sixty, PD can strike at any age, with an estimated prevalence of 41 per 100,000 people in their forties. And while not fatal in and of itself, the progressive neurodegeneration that is characteristic of PD can often cause secondary effects that lead to death.
The exact cause of PD is still a mystery, but researchers believe that both genetics and the environment are likely to play a part. Importantly though, all PD patients show a loss of dopaminergic neurons in the brain and increased levels of a protein called ?-synuclein, which accumulates in Lewy bodies. Lewy bodies are a pathological feature of both familial and sporadic forms of the disease, as well as some types of dementia.
In the study published this month in Scientific Reports, the team led by researchers from Osaka University’s Graduate School of Medicine focused on ?-synuclein as a target for a novel PD treatment.
“Although there are drugs that treat the symptoms associated with PD, there is no fundamental treatment to control the onset and progression of the disease,” explains lead author Takuya Uehara. “Therefore, we looked at ways to prevent the expression of ?-synuclein and effectively eliminate the physiological cause of PD.”
To do this, the researchers designed short fragments of DNA that are mirror images of sections of the ?-synuclein gene product. The constructs were stabilized by the addition of amido-bridging. The resulting fragments, called amido-bridged nucleic acid-modified antisense oligonucleotides (ASOs), bind to their matching mRNA sequence, preventing it from being translated into protein. After screening 50 different ASOs, the researchers settled on a 15-nucleotide sequence that decreased ?-synuclein mRNA levels by 81%.
“When we tested the ASO in a mouse model of PD, we found that it was delivered to the brain without the need for chemical carriers,” says co-lead author Chi-Jing Choong. “Further testing showed that the ASO effectively decreased ?-synuclein production in the mice and significantly reduced the severity of disease symptoms within 27 days of administration.”
Explains senior author of the study Hideki Mochizuki, “Our results showed that gene therapy using ?-synuclein-targeting ASOs is a promising strategy for the control and prevention of PD. We expect that in the future, this method will be used to not only successfully treat PD, but also dementia caused by ?-synuclein accumulation.”
Learn more: Stopping Parkinson’s disease before it starts
The Latest on: Parkinson’s disease
via Google News
The Latest on: Parkinson’s disease
- Billy Connolly on his Parkinson's diagnosis and what he would do as PMon August 20, 2019 at 7:24 am
Billy Connolly: The Sex Life of Bandages will be shown on October 10 at select cinemas across the UK for one night only and features a show from the Australian leg of his last ever stand-up tour in ...
- Rosemary Parkinsonon August 19, 2019 at 7:26 pm
Rosemary Parkinson, age 85 of Darlington, WI passed away Friday, August 16, 2019 at Meriter Hospital in Madison, WI. She was born January 29, 1934 in Madison the daughter of Hans and Julia (Christen) ...
- Neurologist Sanjay Yathiraj to speak on Parkinson’s and sleep issueson August 19, 2019 at 5:16 am
Many people struggle with sleep issues, but for people with Parkinson’s disease (PD), the rest and renewal of a good night’s sleep can be exceptionally elusive. On September 7, Dr. Sanjay Yathiraj, a ...
- Programs help patients with Parkinson's diseaseon August 18, 2019 at 4:00 am
If you or someone you love is dealing with Parkinson's disease at any stage, it may be time to get BIG and LOUD. Parkinson's disease can impair a patient's ability to speak and move. In particular, it ...
- Parkinson, Stephen lead Reading to 7-1 win over Trentonon August 17, 2019 at 6:36 pm
READING, Pa. (AP) -- Josh Stephen hit a two-run home run and had two hits, and David Parkinson allowed just three hits over six innings as the Reading Fightin Phils topped the Trenton Thunder 7-1 on ...
- Using math to help treat Alzheimer’s, Parkinson’s and other diseaseson August 17, 2019 at 7:12 am
Protein aggregation — in which misfolded proteins clump together to form large fibrils — has been implicated in many diseases including Alzheimer’s, Parkinson’s, and type II diabetes. While the exact ...
- Researchers Seek to Determine Genetic Variability in Parkinson Progressionon August 17, 2019 at 5:18 am
Researchers said taking genetic variability into account in the future will be helpful not only to understand the course of Parkinson disease but also to minimize heterogeneity in clinical trials. A ...
- Thieves Attack Seattle Man with Parkinson's, Steal Late Wife's English Bulldogon August 15, 2019 at 12:21 pm
Officials are looking for three people accused of stealing a beloved dog from a 68-year-old man in Seattle.
- New 2019 Report: Parkinsons Disease Treatments Market Expanding Massively With Focusing On Leading Players Novartis, GSK and Merckon August 15, 2019 at 12:45 am
Aug 15, 2019 (WiredRelease via COMTEX) -- Market.us adds comprehensive “Future Growth: Parkinsons Disease Treatments Market” report which focuses on the major industry growth drivers, threats, ...
- Estrogen Protects The Brain From Parkinson’s Diseaseon August 14, 2019 at 12:58 am
There are nearly 500,000 people currently living with Parkinson's disease in the U.S. Researchers hope to reduce that number or prevent new cases with a new potential treatment to fight the ...
via Bing News